VIVUS INC Patent Applications Rejected
48 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2020-06-05: Application 16893998; Invention PHARMACEUTICAL FORMULATIONS; Applicant Vivus, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-02-20: Application 16796194; Invention ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY; Applicant Vivus, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-02-20: Application 16796189; Invention LOW DOSE TOPIRAMATE/; Applicant Vivus, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-01-03: Application 16733559; Invention METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS; Applicant Vivus, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2020-06-05 | 16893998 | PHARMACEUTICAL FORMULATIONS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210113477A1 | Narinder S. BANAIT Leo GU | United States United States | SONG, JIANFENG |
| 2020-02-20 | 16796194 | ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200188352A1 | Thomas NAJARIAN Peter Y. TAM Leland F. WILSON | United States United States United States | AHMED, HASAN SYED |
| 2020-02-20 | 16796189 | LOW DOSE TOPIRAMATE/ | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200188313A1 | Thomas NAJARIAN Peter Y. TAM Leland F. WILSON | United States United States United States | AHMED, HASAN SYED |
| 2020-01-03 | 16733559 | METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200179332A1 | Wesley DAY Barbara TROUPIN | United States United States | SHIAO, REI TSANG |
| 2020-01-02 | 16732544 | COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Vivus, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20200129474A1 | Thomas NAJARIAN | United States | |
| 2020-01-02 | 16732508 | METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200135318A1 | Michael MILLER Barbara TROUPIN | United States United States | LULTSCHIK, WILLIAM G |
| 2019-10-02 | 16590703 | ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200030239A1 | Calvin Theodore BROMAN Eric SHEU | United States United States | JAVANMARD, SAHAR |
| 2019-04-11 | 16381128 | COMBINATION THERAPY FOR PULMONARY HYPERTENSION | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200069658A1 | Leo GU Paul C. NAKAGAKI Narinder S. BANAIT | United States United States United States | LEE, ANDREW P |
| 2019-03-21 | 16360114 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PULMONARY HYPERTENSION | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200054613A1 | Narinder S. BANAIT Leo GU | United States United States | DECK, JASON A |
| 2019-03-08 | 16296436 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200069716A1 | Charles H. BOWDEN Craig PETERSON | United States United States | HENRY, MICHAEL C |
| 2019-01-18 | 16251231 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190374505A1 | Craig Peterson | United States | BAEK, BONG-SOOK |
| 2018-12-14 | 16220292 | PHARMACEUTICAL FORMULATIONS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190350864A1 | Narinder S. BANAIT Leo GU | United States United States | SONG, JIANFENG |
| 2018-12-14 | 16220276 | ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190350897A1 | Thomas NAJARIAN Peter Y. TAM Leland F. WILSON | United States United States United States | AHMED, HASAN SYED |
| 2018-12-14 | 16220269 | LOW DOSE TOPIRAMATE/ | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190350866A1 | Thomas NAJARIAN Peter Y. TAM Leland F. WILSON | United States United States United States | AHMED, HASAN SYED |
| 2018-08-22 | 16108396 | ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190209595A1 | Calvin Theodore BROMAN Eric SHEU | United States United States | BERRIOS, JENNIFER A |
| 2018-07-31 | 16049989 | METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190201374A1 | Wesley DAY Barbara TROUPIN | United States United States | SHIAO, REI TSANG |
| 2018-07-03 | 16026886 | COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190167633A1 | Thomas NAJARIAN | United States | MAIER, LEIGH C |
| 2018-06-21 | 16014093 | ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190133955A1 | Calvin Theodore BROMAN Eric SHEU | United States United States | JAVANMARD, SAHAR |
| 2018-06-14 | 16008808 | METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190139635A1 | Michael MILLER Barbara TROUPIN | United States United States | LULTSCHIK, WILLIAM G |
| 2018-06-13 | 16007420 | METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190142786A1 | Peter TAM Roman DVORAK Craig PETERSON | United States United States United States | CHUI, MEI PING |
| 2018-02-15 | 15753033 | PHARMACEUTICAL FORMULATIONS | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20180243224A1 | Narinder S. BANAIT Leo GU | United States United States | SONG, JIANFENG |
| 2018-01-16 | 15872591 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SLEEP APNEA | VIVUS, INC. | Abandoned -- Incomplete Application (Pre-examination) | US20180140573A1 | Thomas Najarian | United States | |
| 2017-11-07 | 15572487 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PULMONARY HYPERTENSION | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180125828A1 | Narinder S. BANAIT Leo GU | United States United States | DECK, JASON A |
| 2017-10-26 | 15795073 | METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180052975A1 | Michael MILLER Barbara TROUPIN | United States United States | LULTSCHIK, WILLIAM G |
| 2017-07-13 | 15543510 | COMBINATION THERAPY FOR PULMONARY HYPERTENSION | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180325875A1 | Leo GU Paul C. NAKAGAKI Narinder S. BANAIT | United States United States United States | LEE, ANDREW P |
| 2017-06-05 | 15614330 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SLEEP APNEA | VIVUS, INC. | Abandoned -- Incomplete Application (Pre-examination) | Thomas Najarian | United States | ||
| 2017-05-05 | 15588077 | Methods and Compositions for the Treatment of Non-Alcoholic Steatohepatitis | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170319540A1 | Craig Peterson | United States | BAEK, BONG-SOOK |
| 2017-03-20 | 15464061 | METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS | Vivus, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Michael MILLER Barbara TROUPIN | United States United States | ||
| 2016-10-24 | 15333059 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SLEEP APNEA | VIVUS, INC. | Abandoned -- Incomplete Application (Pre-examination) | Thomas Najarian | United States | ||
| 2016-07-06 | 15203601 | Low Dose Topiramate/ | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170151179A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson | United States United States United States | AHMED, HASAN SYED |
| 2016-06-03 | 15172448 | Combination Therapy for Effecting Weight Loss and Treating Obesity | VIVUS, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170119730A1 | Thomas Najarian | United States | MAIER, LEIGH C |
| 2016-05-10 | 15150907 | ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20160250180A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson | United States United States United States | AHMED, HASAN SYED |
| 2015-12-15 | 14970421 | Low Dose Topiramate/ | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160310446A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson | United States United States United States | AHMED, HASAN SYED |
| 2015-10-08 | 14878235 | ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160022630A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson | United States United States United States | AHMED, HASAN SYED |
| 2015-08-13 | 14825284 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20160045527A1 | Charles H. Bowden Craig Peterson | United States United States | HENRY, MICHAEL C |
| 2015-07-22 | 14805881 | Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160015730A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson Craig Peterson | United States United States United States United States | MAIER, LEIGH C |
| 2015-05-15 | 14713938 | ORALLY ADMINISTRATABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150328246A1 | Calvin Theodore Broman Eric Sheu | United States United States | BERRIOS, JENNIFER A |
| 2015-05-06 | 14705229 | TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENT | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150231110A1 | Leland F. Wilson Peter Y. Tam Thomas Najarian Charles H. Bowden | United States United States United States United States | KANTAMNENI, SHOBHA |
| 2015-04-06 | 14679754 | Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150209325A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson | United States United States United States | AHMED, HASAN SYED |
| 2015-04-06 | 14679719 | LOW DOSE TOPIRAMATE / | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150313870A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson | United States United States United States | AHMED, HASAN SYED |
| 2014-10-09 | 14510639 | Compositions and Methods for the Treatment of Sleep Apnea | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20150025134A1 | Thomas Najarian | United States | MAIER, LEIGH C |
| 2014-06-27 | 14317845 | COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140308346A1 | Thomas NAJARIAN | United States | MAIER, LEIGH C |
| 2014-03-17 | 14216796 | METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140294950A1 | Peter TAM Roman DVORAK Craig PETERSON | United States United States United States | CHUI, MEI PING |
| 2014-03-14 | 14213498 | METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS | VIVUS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140288944A1 | Michael MILLER Barbara TROUPIN | United States United States | LULTSCHIK, WILLIAM G |
| 2013-10-17 | 14056109 | Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active Agent | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140094511A1 | Leland F. Wilson Peter Y. Tam Thomas Najarian Charles H. Bowden | United States United States United States United States | KANTAMNENI, SHOBHA |
| 2013-09-12 | 14025051 | Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140088162A1 | Thomas Najarian Peter Y. Tam Leland F. Wilson Craig Peterson | United States United States United States United States | MAIER, LEIGH C |
| 2013-07-18 | 13945430 | Methods and Compositions for the Treatment of Estrogen-Dependent Hyperproliferative Uterine Disorders | Vivus, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140080794A1 | Changjin Wang Leland F. Wilson | United States United States | HUI, SAN MING R |
| 2013-02-25 | 13776166 | NOVEL COMPOSITIONS COMPRISING A PHOSPHODIESTERASE-5 INHIBITOR AND THEIR USE IN METHODS OF TREATMENT | VIVUS, Inc. | Abandoned -- Failure to Respond to an Office Action | US20130296324A1 | Jerry M. Held | United States | MCMILLIAN, KARA RENITA |